SLC2A1 Gene

HGNC Family Solute carriers (SLC)
Name solute carrier family 2 (facilitated glucose transporter), member 1
Description This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC2A1, encoding the facilitative glucose transporter GLUT1, is central to cellular glucose uptake via passive diffusion. Structural and mutational studies have revealed that GLUT1 adopts a canonical major facilitator superfamily fold with a central aqueous channel that alternates between inward‐ and outward‐facing conformations, thereby enabling efficient glucose transport. Posttranslational modifications such as S‐palmitoylation and regulation by insulin–Akt signals ensure appropriate plasma membrane localization and function, a feature that is also supported by crystallographic snapshots of the inward‐open conformation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn normal physiology, GLUT1 is indispensable for maintaining metabolic homeostasis in diverse tissues. In CD4(+) T lymphocytes, for example, GLUT1 expression is finely tuned to regulate the balance between metabolically glycolytic effector T cells and lipid‐dependent regulatory T cells, with its expression being modulated by factors such as TXNIP and even exploited as a receptor by viral glycoproteins. At barrier sites like the blood–brain barrier and in the placenta, GLUT1 ensures a continuous supply of glucose—critical for brain function and maternofetal nourishment. Moreover, genetic defects in SLC2A1 underlie GLUT1 deficiency syndrome, a condition characterized by low cerebrospinal fluid glucose, epilepsy, paroxysmal dyskinesias, and distinctive electroencephalographic abnormalities."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer and other pathologic states, aberrant up‐regulation of GLUT1 fuels the elevated glycolytic rates—often referred to as the “Warburg Effect”—that support rapid proliferation and survival in hostile microenvironments. Elevated GLUT1 expression has been consistently documented in hepatocellular, endometrial, breast, lung, renal, and oral carcinomas, where it is often linked to activation of oncogenic signaling pathways like PI3K/AKT/mTOR. Furthermore, certain SLC2A1 mutations not only reduce glucose transport but can also confer a neomorphic ion conductance, contributing to paroxysmal movement disorders. In addition, altered GLUT1 function affects cellular bioenergetics as seen with the development of specific FRET‐based nanosensors that highlight its role in glucose flux."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its core metabolic role, GLUT1 has emerged as a promising clinical biomarker and therapeutic target. Its dysregulation contributes not only to tumor aggressiveness and altered energy metabolism in cancer—impacting tumor proliferation, invasion, and even the local immune landscape—but also to immune dysfunction as observed in leukemic contexts. Epigenetic regulators, including m6A RNA methylation, as well as differential expression patterns in leukocytes, further underscore the multifaceted regulatory landscape governing GLUT1 expression. Elevated GLUT1 levels have also been associated with diabetic complications and certain thyroid malignancies, emphasizing the broad clinical relevance of SLC2A1 dysregulation and the potential for targeted intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "36", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Dong Deng, Chao Xu, Pengcheng Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structure of the human glucose transporter GLUT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature13306"}], "href": "https://doi.org/10.1038/nature13306"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24847886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24847886"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Knut Brockmann "}, {"type": "b", "children": [{"type": "t", "text": "The expanding phenotype of GLUT1-deficiency syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Dev (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.braindev.2009.02.008"}], "href": "https://doi.org/10.1016/j.braindev.2009.02.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19304421"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19304421"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "P W Hruz, M M Mueckler "}, {"type": "b", "children": [{"type": "t", "text": "Structural analysis of the GLUT1 facilitative glucose transporter (review)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Membr Biol (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/09687680110072140"}], "href": "https://doi.org/10.1080/09687680110072140"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11681785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11681785"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Sagan KC, Juan M Cárcamo, David W Golde "}, {"type": "b", "children": [{"type": "t", "text": "Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.05-4107com"}], "href": "https://doi.org/10.1096/fj.05-4107com"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16195374"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16195374"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Muheeb Beg, Nazish Abdullah, Fathima Shazna Thowfeik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.26896"}], "href": "https://doi.org/10.7554/eLife.26896"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28589878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28589878"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Koen Veys, Zheng Fan, Moheb Ghobrial, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.119.316463"}], "href": "https://doi.org/10.1161/CIRCRESAHA.119.316463"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32404031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32404031"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ryan D Michalek, Valerie A Gerriets, Sarah R Jacobs, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1003613"}], "href": "https://doi.org/10.4049/jimmunol.1003613"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21317389"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21317389"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ning Wu, Bin Zheng, Adam Shaywitz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2013.01.035"}], "href": "https://doi.org/10.1016/j.molcel.2013.01.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23453806"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23453806"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Nicolas Manel, Felix J Kim, Sandrina Kinet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0092-8674(03)00881-x"}], "href": "https://doi.org/10.1016/s0092-8674(03"}, {"type": "t", "text": "00881-x) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14622599"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14622599"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ramzi Shawahna, Yasuo Uchida, Xavier Declèves, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharm (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/mp200129p"}], "href": "https://doi.org/10.1021/mp200129p"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21707071"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21707071"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Marc U Baumann, Sylvie Deborde, Nicholas P Illsley "}, {"type": "b", "children": [{"type": "t", "text": "Placental glucose transfer and fetal growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrine (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1385/ENDO:19:1:13"}], "href": "https://doi.org/10.1385/ENDO:19:1:13"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12583599"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12583599"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Arvid Suls, Peter Dedeken, Karolien Goffin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awn113"}], "href": "https://doi.org/10.1093/brain/awn113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18577546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18577546"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Arvid Suls, Saul A Mullen, Yvonne G Weber, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.21724"}], "href": "https://doi.org/10.1002/ana.21724"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19798636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19798636"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "S A Mullen, A Suls, P De Jonghe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e3181eb58b4"}], "href": "https://doi.org/10.1212/WNL.0b013e3181eb58b4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20574033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20574033"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Roser Pons, Abbie Collins, Michael Rotstein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The spectrum of movement disorders in Glut-1 deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mov Disord (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mds.22808"}], "href": "https://doi.org/10.1002/mds.22808"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20063428"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20063428"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Séverine Loisel-Meyer, Louise Swainson, Marco Craveiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glut1-mediated glucose transport regulates HIV infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1121427109"}], "href": "https://doi.org/10.1073/pnas.1121427109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22308487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22308487"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Linda D Leary, Dong Wang, Douglas R Nordli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsia (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1528-1157.2003.05302.x"}], "href": "https://doi.org/10.1046/j.1528-1157.2003.05302.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12752470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12752470"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Thomas Amann, Ulrike Maegdefrau, Arndt Hartmann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2009.080596"}], "href": "https://doi.org/10.2353/ajpath.2009.080596"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19286567"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19286567"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Yvonne G Weber, Alexander Storch, Thomas V Wuttke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI34438"}], "href": "https://doi.org/10.1172/JCI34438"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18451999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18451999"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hitomi Takanaga, Bhavna Chaudhuri, Wolf B Frommer "}, {"type": "b", "children": [{"type": "t", "text": "GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamem.2007.11.015"}], "href": "https://doi.org/10.1016/j.bbamem.2007.11.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18177733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18177733"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Anna Krzeslak, Katarzyna Wojcik-Krowiranda, Ewa Forma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Oncol Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12253-012-9500-5"}], "href": "https://doi.org/10.1007/s12253-012-9500-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22270867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22270867"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Kátia C Carvalho, Isabela W Cunha, Rafael M Rocha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clinics (Sao Paulo) (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1590/s1807-59322011000600008"}], "href": "https://doi.org/10.1590/s1807-59322011000600008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21808860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21808860"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Marcelo Mamede, Tatsuya Higashi, Masanori Kitaichi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.04577"}], "href": "https://doi.org/10.1593/neo.04577"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15967114"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15967114"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Hideki Makinoshima, Masahiro Takita, Koichi Saruwatari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.660498"}], "href": "https://doi.org/10.1074/jbc.M115.660498"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26023239"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26023239"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Khyati Kapoor, Janet S Finer-Moore, Bjørn P Pedersen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1603735113"}], "href": "https://doi.org/10.1073/pnas.1603735113"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27078104"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27078104"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Leszek Szablewski "}, {"type": "b", "children": [{"type": "t", "text": "Glucose Transporters in Brain: In Health and in Alzheimer's Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Alzheimers Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/JAD-160841"}], "href": "https://doi.org/10.3233/JAD-160841"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27858715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27858715"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Laura J McCulloch, Martijn van de Bunt, Matthias Braun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Metab (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymgme.2011.08.026"}], "href": "https://doi.org/10.1016/j.ymgme.2011.08.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21920790"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21920790"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "C Pinheiro, B Sousa, A Albergaria, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-26.1279"}], "href": "https://doi.org/10.14670/HH-26.1279"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21870331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21870331"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Qin Wu, Wail Ba-Alawi, Genevieve Deblois, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-020-18020-8"}], "href": "https://doi.org/10.1038/s41467-020-18020-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32826891"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32826891"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Susana C Rosa, Juliana Gonçalves, Fernando Judas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Res Ther (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/ar2713"}], "href": "https://doi.org/10.1186/ar2713"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19490621"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19490621"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Katrin Singer, Michael Kastenberger, Eva Gottfried, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.25543"}], "href": "https://doi.org/10.1002/ijc.25543"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20607826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20607826"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Fernanda Rocha Rojas Ayala, Rafael Malagoli Rocha, Kátia Cândido Carvalho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Molecules (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/molecules15042374"}], "href": "https://doi.org/10.3390/molecules15042374"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20428049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20428049"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Sunhwa Oh, Hyungjoo Kim, KeeSoo Nam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMB Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5483/bmbrep.2017.50.3.189"}], "href": "https://doi.org/10.5483/bmbrep.2017.50.3.189"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27931517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27931517"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Alice R Gardiner, Fatima Jaffer, Russell C Dale, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The clinical and genetic heterogeneity of paroxysmal dyskinesias."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awv310"}], "href": "https://doi.org/10.1093/brain/awv310"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26598494"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26598494"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Laleh G Melstrom, Mohammad R Salabat, Xian-Zhong Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pancreas (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MPA.0b013e3181735ccb"}], "href": "https://doi.org/10.1097/MPA.0b013e3181735ccb"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18953257"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18953257"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Peter J Siska, Gerritje J W van der Windt, Rigel J Kishton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1502464"}], "href": "https://doi.org/10.4049/jimmunol.1502464"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27511728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27511728"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Huarong Chen, Shanshan Gao, Weixin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RNA N"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A-GLUT1-mTORC1 Axis and Is a Therapeutic Target."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2020.11.013"}], "href": "https://doi.org/10.1053/j.gastro.2020.11.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33217448"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33217448"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Yuchang Fu, Lidia Maianu, Barry R Melbert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Cells Mol Dis (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcmd.2003.09.002"}], "href": "https://doi.org/10.1016/j.bcmd.2003.09.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14757434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14757434"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Sotoodeh Abhary, Alex W Hewitt, Kathryn P Burdon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A systematic meta-analysis of genetic association studies for diabetic retinopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db09-0059"}], "href": "https://doi.org/10.2337/db09-0059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19587357"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19587357"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Caterina Mian, Susi Barollo, Gianmaria Pennelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2265.2007.03008.x"}], "href": "https://doi.org/10.1111/j.1365-2265.2007.03008.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17854396"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17854396"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Paolo Fusar-Poli, Andreas Meyer-Lindenberg "}, {"type": "b", "children": [{"type": "t", "text": "Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Bull (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/schbul/sbr180"}], "href": "https://doi.org/10.1093/schbul/sbr180"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22282454"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22282454"}]}]}]}
Synonyms GLUT-1, GLUT1DS, CSE, DYT9, SDCHCN, GLUT, GLUT1, DYT17, HTLVR, DYT18, EIG12
Proteins GTR1_HUMAN
NCBI Gene ID 6513
API
Download Associations
Predicted Functions View SLC2A1's ARCHS4 Predicted Functions.
Co-expressed Genes View SLC2A1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View SLC2A1's ARCHS4 Predicted Functions.

Functional Associations

SLC2A1 has 20,193 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 143 datasets.

Click the + buttons to view associations for SLC2A1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by SLC2A1 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC2A1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC2A1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC2A1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of SLC2A1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of SLC2A1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC2A1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of SLC2A1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC2A1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC2A1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of SLC2A1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC2A1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of SLC2A1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with SLC2A1 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with SLC2A1 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC2A1 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of SLC2A1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of SLC2A1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations phenotypes associated with SLC2A1 gene from the curated ClinVar Gene-Phenotype Associations dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with SLC2A1 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC2A1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing SLC2A1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing SLC2A1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing SLC2A1 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with SLC2A1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with SLC2A1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC2A1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with SLC2A1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with SLC2A1 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with SLC2A1 gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of SLC2A1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving SLC2A1 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving SLC2A1 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with SLC2A1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with SLC2A1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with SLC2A1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with SLC2A1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for SLC2A1 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC2A1 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC2A1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of SLC2A1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing SLC2A1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with SLC2A1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with SLC2A1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of SLC2A1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with SLC2A1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing SLC2A1 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of SLC2A1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC2A1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of SLC2A1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC2A1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of SLC2A1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of SLC2A1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding SLC2A1 protein from the GlyGen Glycosylated Proteins dataset.
GO Biological Process Annotations 2015 biological processes involving SLC2A1 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving SLC2A1 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving SLC2A1 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing SLC2A1 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing SLC2A1 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing SLC2A1 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by SLC2A1 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by SLC2A1 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by SLC2A1 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of SLC2A1 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of SLC2A1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of SLC2A1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC2A1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of SLC2A1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding SLC2A1 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with SLC2A1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with SLC2A1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with SLC2A1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC2A1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for SLC2A1 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of SLC2A1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of SLC2A1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of SLC2A1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC2A1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPM Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of SLC2A1 protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with SLC2A1 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for SLC2A1 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuBMAP ASCT+B Annotations cell types associated with SLC2A1 gene from the HuBMAP ASCT+B dataset.
HuBMAP ASCT+B Augmented with RNA-seq Coexpression cell types associated with SLC2A1 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with SLC2A1 gene from the HuBMAP Azimuth Cell Type Annotations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with SLC2A1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for SLC2A1 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of SLC2A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of SLC2A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of SLC2A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways pathways involving SLC2A1 protein from the KEGG Pathways dataset.
KEGG Pathways 2026 pathways involving SLC2A1 protein from the KEGG Pathways 2026 dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate SLC2A1 protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC2A1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC2A1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with SLC2A1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of SLC2A1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of SLC2A1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of SLC2A1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC2A1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain SLC2A1 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by SLC2A1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting SLC2A1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of SLC2A1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of SLC2A1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by SLC2A1 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for SLC2A1 from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of SLC2A1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of SLC2A1 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing SLC2A1 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
OMIM Gene-Disease Associations phenotypes associated with SLC2A1 gene from the curated OMIM Gene-Disease Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for SLC2A1 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC2A1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of SLC2A1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving SLC2A1 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving SLC2A1 protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with SLC2A1 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PID Pathways pathways involving SLC2A1 protein from the PID Pathways dataset.
ProteomicsDB Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of SLC2A1 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset.
Reactome Pathways 2014 pathways involving SLC2A1 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving SLC2A1 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC2A1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC2A1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of SLC2A1 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of SLC2A1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC2A1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC2A1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of SLC2A1 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of SLC2A1 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with SLC2A1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of SLC2A1 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of SLC2A1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of SLC2A1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of SLC2A1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of SLC2A1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of SLC2A1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of SLC2A1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC2A1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of SLC2A1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC2A1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with SLC2A1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with SLC2A1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving SLC2A1 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving SLC2A1 protein from the WikiPathways Pathways 2024 dataset.